-
-
-
-
-
-
-
Disc Medicine (IRON) Reiterated at Buy by Stifel After P3 INSPIRE Results
-
-
-
-
-
-
-
Stifel on Disc Medicine (IRON): 'More Speculative Regulatory Chatter Emerges – We’re Still Bullish on Risk/Reward Here'
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Disc Medicine (IRON)
-
-
-
-
-
-
-
Truist Securities: 'Is Biotech Back?!'
-
-
-
-
-
-
-
Disc Medicine submits FDA application for rare blood disorder drug
-
-
-
-
-
-
-
Morgan Stanley Assumes Disc Medicine (IRON) at Overweight
-
-
-
-
-
-
-
Disc Medicine (IRON) PT Raised to $75 at Scotiabank
-
447,734 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

